Image
GPS (Galderma Patient Services) for NEMLUVIO™ (nemolizumab-ilto).

Not an actual patient.

A seamless treatment experience starts here

From day 1, GPS (Galderma Patient Services) for NEMLUVIO™ can provide guidance and support to help you manage your treatment experience. The support team can help you understand insurance benefits and financial assistance, provide one-on-one education, and help you stay on track, including refill reminders. They can help ensure a seamless start and continuation of your treatment with NEMLUVIO®.

What to expect as you start your treatment

Consider which of the following support programs will be most useful to you:

Image

Quick Start: Dose(s) of NEMLUVIO free of charge for those who qualify, are commercially insured, and are experiencing insurance delays due to the authorization process

Image

Co-Pay Assistance: Helps with out-of-pocket expenses if you are commercially insured

Image

Nurse Navigators: Your guides to NEMLUVIO, providing you with the knowledge foundation to embark on a successful treatment experience

Image

Sharps Program: A convenient mail-back option to properly dispose of spent injectors

Image

Bridge: Helps you access your treatment if you have a gap in your insurance or another insurance issue while your dermatologist pursues approval

Image

Patient Assistance Program: Provides access support if you are uninsured or underinsured and meet the program requirements

Image

Product Replacement: Replacement dose(s) due to product defect or error during administration to keep you on track

It's easy to enroll with GPS for NEMLUVIO

You can get started with GPS for NEMLUVIO by completing your enrollment form online today. The GPS for NEMLUVIO support team will be in touch to connect you with the right programs and access to treatment.

If you prefer to enroll over the phone or have questions about GPS for NEMLUVIO, please call 1-855-NEMLUVIO, 8:00 AM - 8:00 PM ET, Monday - Friday

If you prefer to enroll over the phone or have questions about GPS for NEMLUVIO, please call 1-855-NEMLUVIO, 8:00 AM - 8:00 PM ET, Monday - Friday

If you prefer to enroll over the phone or have questions about GPS for NEMLUVIO, please call 1-855-NEMLUVIO,
8:00 AM - 8:00 PM ET, Monday - Friday

HELPFUL RESOURCES AT YOUR FINGERTIPS

Discover the patient brochure, dermatologist discussion guide, and more to help support your experience with NEMLUVIO.

Important Safety Information

Indication: NEMLUVIO® (nemolizumab-ilto) is a prescription medicine used to treat adults with prurigo nodularis.

Do not take NEMLUVIO if you are allergic to nemolizumab-ilto or to any ingredients in NEMLUVIO.

Before taking NEMLUVIO, tell your healthcare provider about all of your medical conditions, including if you:

  • are scheduled to receive any vaccination. You should not receive a live vaccine right before or during treatment with NEMLUVIO.
  • are pregnant or plan to become pregnant. It is not known whether NEMLUVIO will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known whether NEMLUVIO passes into your breast milk and if it can harm your baby.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

NEMLUVIO may cause serious side effects, including: allergic reactions (hypersensitivity). Stop using NEMLUVIO and tell your healthcare provider or get emergency help right away if you get any of the following symptoms:

  • Breathing problems or wheezing
  • Swelling of the face, lips, mouth, tongue, or throat
  • Fainting, dizziness, feeling lightheaded
  • Fast pulse
  • Swollen lymph nodes
  • Joint pain
  • Fever
  • Skin rash (red or rough skin)
  • Nausea or vomiting
  • General ill feeling
  • Cramps in your stomach area

The most common side effects of NEMLUVIO include:

  • Headache
  • Skin rashes: atopic dermatitis (a type of eczema), eczema, and eczema nummular (scattered circular patches)

These are not all of the possible side effects of NEMLUVIO.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1‑800‑FDA‑1088.

Please see full Prescribing Information, including Patient Information.